news
BenevolentAI becomes first AI company to appoint a Chief Medical Officer
BenevolentAI is the first AI company to have a CMO on its staff.
List view / Grid view
AstraZeneca
news
ESCMID and ASM’s review need for new strategies and tactics to fight antimicrobial resistance
11 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the American Society for Microbiology (ASM) have just closed a joint conference in Vienna, which aimed to help researchers accelerate the development of new antimicrobials and to shed light on the challenges associated with antimicrobial resistance.
news
IDF calls for internationally standardised monitoring of cardiovascular disease in diabetics
29 September 2016 | By Niamh Louise Marriott, Digital Content Producer
It is difficult to estimate the global burden of cardiovascular disease in people with diabetes, due to lack of data and standardisation...
article
Imaging In-Depth Focus 2016
In this Imaging In-Depth Focus: Norman Peterson, from MedImmune/AstraZeneca, looks at the practical application of in vivo optical imaging in biotherapeutic biodistribution analyses. Plus, experts from MRC Technology discuss high-content imaging in drug discovery, and Molecular Devices feature in our Q&A...
news
‘Library’ of de-prioritised pharma compounds available for researchers
UK scientists can apply for MRC funding to use any of the compounds in medical research studies to investigate the underlying mechanics of disease...
news
MRC Technology, AstraZeneca, Asthma UK and British Lung Foundation to collaborate on respiratory disease research
1 September 2016 | By Niamh Louise Marriott, Digital Content Producer
A collaboration to investigate the link between epigenetics and respiratory disease and to find new drug treatments involves...
news
Chronos Therapeutics appoints new VPs for MS and PTSD research
4 August 2016 | By Niamh Marriott, Digital Content Producer
Chronos Therapeutics, a biotech company researching ageing diseases, brain and nervous system disorders, have announced the appointment of Dr Fraser Murray and Dr Timothy Schulz-Utermoehl, as Vice Presidents of Pre-Clinical Development...
news
New initiative to find epigenetic drug targets in respiratory disease
15 June 2016 | By Victoria White, Digital Content Producer
MRCT and AstraZeneca are seeking academics with relevant epigenetics targets to collaborate with them to develop novel treatments for respiratory diseases...
news
AstraZeneca’s genomics initiative to transform drug discovery
22 April 2016 | By Victoria White, Digital Content Producer
AstraZeneca has launched an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline...
news
ADDoPT project set to transform the UK pharma industry
28 January 2016 | By Victoria White
The ADDoPT project addresses the key challenge of getting new innovative medicines to market in the quickest and most cost-effective way...
news
Apollo Therapeutics Fund launched to drive therapeutic innovation
25 January 2016 | By Victoria White
The Apollo Therapeutics Fund will support the translation of ground-breaking academic science into innovative new medicines for a broad range of diseases...
news
AstraZeneca and Moderna enter mRNA therapy collaboration
11 January 2016 | By Victoria White
mRNA-based therapies are an innovative treatment approach that enables the body to produce therapeutic protein in vivo, opening up new treatment options for a wide range of diseases...
news
AstraZeneca and MedImmune to harness the power of the Secretome
11 December 2015 | By Victoria White
The companies have joined WCPR to develop new technologies for biologics production and to identify new targets for disease research in the ground-breaking area of the Secretome...
news
Pelago and AstraZeneca enter CETSA research collaboration
27 November 2015 | By
Pelago and AstraZeneca will together develop assay formats and applications of the CETSA method relevant across the range of AstraZeneca’s therapeutic areas...
news
AstraZeneca invests in its Cambridge lead discovery centre
20 November 2015 | By Victoria White
The company has announced three new partnerships that will deliver a collaborative screening platform, space-age robotics, and sound waves that can move liquids...
